Similar articles

• Markers of disordered immunoregulation.

  Little JR, Schwartz BD. Little JR, et al. Arch Intern Med. 1983 Aug;143(8):1575-9. Arch Intern Med. 1983. PMID: 6603203 No abstract available.
• [Rheumatoid vasculitis].

  Nagafuchi H, Ozaki S. Nagafuchi H, et al. Nihon Rinsho. 2005 Jan;63 Suppl 1:274-7. Nihon Rinsho. 2005. PMID: 15799360 Review. Japanese. No abstract available.
• IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

  Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. Scott DG, et al. Clin Exp Immunol. 1981 Jan;43(1):54-63. Clin Exp Immunol. 1981. PMID: 7249394 Free PMC article.
• Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis.

  Winkelstein A, Starz TW, Agarwal A. Winkelstein A, et al. J Rheumatol. 1984 Apr;11(2):162-6. J Rheumatol. 1984. PMID: 6726715
• [Rheumatoid arthritis, malignant rheumatoid arthritis].

  Hirohata S. Hirohata S. Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):265-8. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11031943 Review. Japanese. No abstract available.